New positive data in Phase III type 2 diabetes trial New positive data in Phase III type 2 diabetes trial DINAMO Phase III trial demonstrated empagliflozin significantly reduced blood sugar levels in children and adolescents with type 2 diabetes
Joint venture to fight Antimicrobial Resistance Joint venture to fight Antimicrobial Resistance Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
FDA- HFpEF-breakthrough-designation-EMPEROR-preserved FDA- HFpEF-breakthrough-designation-EMPEROR-preserved U.S. FDA issues Breakthrough Therapy Designation for the treatment of adults with heart failure with preserved ejection fraction
empulse-trial-benefit-acute-heart-failure empulse-trial-benefit-acute-heart-failure Empagliflozin provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE Phase III trial
emperor-preserved-heart-failure-toplineresults emperor-preserved-heart-failure-toplineresults Positive, top-line results announced from the EMPEROR-Preserved Phase III trial in adults with heart failure with preserved ejection fraction
emperor-reduced-chmp-positive-opinion emperor-reduced-chmp-positive-opinion CHMP issues positive opinion for the treatment of adults with heart failure with reduced ejection fraction
Aservo EquiHaler wins Pharmapack Award 2021 Aservo EquiHaler wins Pharmapack Award 2021 Boehringer Ingelheim’s Aservo® EquiHaler® is recognized in the 2021 Pharmapack Awards
EHS management approach EHS management approach We protect our employees, facilities and the environment from harmful influences, conserve natural resources and promote environmental awareness
Expertise in microbial | Bioxcellence | Boehringer Ingelheim Expertise in microbial | Bioxcellence | Boehringer Ingelheim Leverage BioXcellence's expertise in microbial production, providing high-quality, reliable biopharmaceutical manufacturing solutions for your business.
Career tips from our Global Head of HR Career tips from our Global Head of HR Sven Sommerlatte explains how important it is to reflect on the personal career strategy.
Cat care interview veterinarian Dr Susan Little Cat care interview veterinarian Dr Susan Little World-renowned feline healthcare specialist Dr. Susan Little shares her thoughts on latest trends in cat care.
Resizing our Carbon Footprint Resizing our Carbon Footprint The ecological balance of the world is at a tipping point.
Partnering with Lifebit to detect global disease outbreaks Partnering with Lifebit to detect global disease outbreaks Boehringer Ingelheim partners with Lifebit to detect global infectious disease outbreaks
Boehringer Ingelheim partners with PetMedix Boehringer Ingelheim partners with PetMedix Partnering with PetMedix on Ky9™ platform cutting edge technology as a means to bring innovative new therapies to improve health of animals
Winners of the 2020 European PRRS Research Award Winners of the 2020 European PRRS Research Award Winners of the 2020 European PRRS Research Award announced Three winner awarded 25,000 euro each for their research.
emperor-preserved-kidney-subanalysis emperor-preserved-kidney-subanalysis New kidney sub-analysis of EMPEROR-Preserved trial demonstrates significant improvement in heart failure outcomes regardless of kidney disease status
World Water Day: Good Health Hinges on Good Water World Water Day: Good Health Hinges on Good Water Clean, safe and accessible water is the most basic prerequisite for life and health
Collaboration Boehringer Ingelheim Veeva technology Collaboration Boehringer Ingelheim Veeva technology Boehringer Ingelheim selects Veeva Development Cloud worldwide to bring innovative therapies to patients faster
Boehringer Ingelheim invests in precision cancer treatments Boehringer Ingelheim invests in precision cancer treatments Boehringer Ingelheim Venture Fund invests in Synthetica as part of its commitment to advancing innovative, next-generation cancer therapies
The power of patient advocacy in cancer care The power of patient advocacy in cancer care Larry, a retired US Navy veteran, and Jeff, UICC President, have more in common than a cancer diagnosis: they share a passion for patient empowerment.
Groundbeaking of vaccine production center in France Groundbeaking of vaccine production center in France Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health
Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer IME launch collaboration which aims to develop sustainable animal health products
Henke-Sass Wolf develop needle free device Henke-Sass Wolf develop needle free device Boehringer Ingelheim partners with Henke-Sass, Wolf to develop innovative needle free injection device for pigs
Winners of 2020 BVDzero Case Awards Winners of 2020 BVDzero Case Awards Winners of 2020 BVDzero Case Awards announced. 10 top clinical cases will receive a total prize of 15,000 euros.
Breakthrough-Therapy-Designation-Progressive-Fibrosing-ILD Breakthrough-Therapy-Designation-Progressive-Fibrosing-ILD FDA Grants nintedanib Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype